Transcript : Supernus Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03
Supernus Pharmaceuticals Inc SUPN
$49.43
▼ -3.46%
($-1.77)
Open
$50.88
Prev Close
$51.20
Day Range
$49.15 – $50.88
52W Range
$30.83 – $59.68
Market Cap
$2.87B
Beta
0.58
EPS (TTM)
$-0.51
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2010-12-28 |
| Shares Out. | 57,580,000 |
| Website | supernus.com ↗ |
| Phone | 13018382500 |
Supernus Pharmaceuticals Inc is a publicly traded company under the ticker symbol SUPN on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
12 analysts (2026-05-01)
📰 Latest News for SUPN
Supernus Pharmaceuticals, Inc. (SUPN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference
Supernus Pharmaceuticals, Inc. (SUPN) Q1 2026 Earnings Call Transcript
Transcript : Supernus Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 05, 2026
Supernus Pharmaceuticals (NASDAQ:SUPN) Beats Q1 Estimates as Growth Products Drive 39% Revenue Surge
Supernus Pharmaceuticals Q1 2026 Earnings Call Transcript
Supernus: Q1 Earnings Snapshot